Use of high dose barbiturates in severe head injury;Indicación del coma barbitúrico en el traumatismo craneoencefálico grave

Medicina Intensiva

Volumn 26, Issue 8, 2002, Pages 407-412

  Pérez Bárcena, Jon ^a   Abadal Centelles, J M ^a   Marse Milla P ^a   Ibanez Juve J ^a  

^a NONE   (Spain)

Author keywords

Barbiturates; Head injury

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMOBARBITAL; APROBARBITAL; BARBITURIC ACID; BUTALBITAL; CYTOCHROME P450; DIALURIC ACID; HEXOBARBITAL; METHOHEXITAL; PENTOBARBITAL; PHENOBARBITAL; PRIMIDONE; SECBUTABARBITAL; SECOBARBITAL; THIAMYLAL; THIOBARBITURIC ACID; THIOPENTAL;

BRAIN INJURY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; HEAD INJURY; HUMAN; HYPOTENSION; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; NEUROTRAUMATOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0038628233     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-5691(02)79819-7     Document Type: Review

References (43)

1. Horsley JS. The intracranial pressure during barbital narcosis. Lancet 1937;1:141-3.
2. Ishii S. Brain swelling: Studies of structural, physiologic, and biochemical alterations. En: Caveness WF, Walker AE, editors. Head Injury, Conference Proceedings. Philadelphia: JB Lippincot 1966; p. 276-83.
3. Rockoff MA, Marshall LF, Shapiro HM. High dose barbiturate therapy in humans: A clinical review of 60 patients. Ann Neurol 1979;6:194-9.
4. Marshall LF, Smith RW, Shapiro HM. The outcome with aggresive treatment in severe head injury. J Neurosurg 1979;50:26-30.
5. Shapiro HM, Wyte SR, Loeser J. Barbiturate augmented hypothermia for reduction of persistent intracranial hypertension. J Neurosurg 1974:40:80-100.
6. Rea GL, Rockswold GL. Barbiturate therapy in uncontrolled intracranial hypertension. Neurosurgery 1983;12:401-5.
7. Sidi A, Cotev S, Hadani M, Wald U, Feisod M, Perel A. Long term barbiturate infusion to reduce intracranial pressure. Crit Care Med 1983;11:478-81.
8. Nordby HK, Nesbakken R. The effect of high dose barbiturate decompression after severe head injury. A controlled clinical trial. Acta Neurochir (Wien) 1984;72:157-66.
9. Bohn DJ, Swan P, Sides C, Hoffman H. High dose barbiturate therapy in the management of severe paediatric head injury: A randomised controlled trial. Crit Care Med 1989;S118:17.
10. Eisenberg HM, Frankowski RF, Contant CF, Marshall LF, Walker MD. High dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg 1988;69:15-23.
11. Levy ML, Aranda M, Zelman V, Giannotta SL. Propylene glycol toxicity following continous etomidate infusion for the control of refractory cerebral edema. Neurosurgery 1995;37:363-71.
12. Saul TG, Ducker TB. Effects of intracranial pressure monitoring and aggresive treatment on mortality in severe head injury. J Neurosurg 1982;56:498-503.
13. Schwartz ML, Tator CH, Rowed DW, Reid SR, Meguro K, Andrews DF. The University of Toronto Head Injury Treatment Study: A prospective randomized comparision of pentobarbital and mannitol. Can J Neurol Sci 1984;11:434-40.
14. Ward JD, Becker DP, Miller JD, Choi SC, Marmarou A, Wood C, et al. Failure of prophylactic barbiturate coma in the treatment of severe head injury. J Neurosurg 1985;62:383-8.
15. Cruz J. Adverse effects of pentobarbital on cerebral venous oxygenation of comatose patients with acute traumatic brain swelling: Relationship to outcome. J Neurosurg 1996;85:758-61.
16. Cormio M, Gopinath S, Valadka A, Robertson CS. Cerebral hemodynamic effects of pentobarbital coma in head injured patients. J Neurotrauma 1999;16:927-35.
17. Goodman JC, Valadka A, Gopinath S, Cormio C. Lactate and excitatory amino acids measured by microdialysis are decreased by pentobarbital coma in head injured patients. J Neurotrauma 1996;13:549-56.
18. Stover JF, Pleines UE, Morganti-Kossmann MC, Stocker R, Kossmann T. Thiopental attenuates energetic impairment but fails to normalize cerebrospinal fluid glutamate in brain-injured patients. Crit Care Med 1999;27:1351-7.
19. The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Use of barbiturates in the control of intracranial hypertension. J Neurotrauma 2000;17:527-30.
20. Roberts I. Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev 2000; (2) :CD 000033.
21. Wollman H, Marshall BE, Harvey SC. En: Gilman AC, Goodman LS, Gilman A, editors. Goodman and Gilman's. The Pharmacological Basis of Therapeutics. 6th Ed. New York: Macmillan 1980. p 292-5.
22. Michenfelder JD. The interdependency of cerebral functional and metabolic effects following massive doses of thiopental in the dog. Anaesthesiology 1974;41:231-6.
23. Reilly P. Management of intracranial pressure and cerebral perfusion. In: Chapman and Hall, editors. Head Injury. Pathophysiology and Management of Severe Closed Injury. London, 1997: p. 385-405.
24. Blaustein MP, Ector AC. Barbiturate inhibition of calcium uptake by depolarised nerve terminals. Molecular Pharmacology 1975;11:369-78.
25. Smith DS, Rehncrona S, Siesjo BK. et al. Inhibitory effects of different barbiturates on lipid peroxidation in brain tissue in vitro. Comparision with the effects of promethazine and chlorpromazine. Anaesthesiology 1980;53:186-94.
26. Yoshida S, Inoh S, Asano T. Brain free fatty acids, aedema and mortality in gerbils subjected to transient bilateral ischaemica, and effects of barbiturate anesthesia. J Neurochemistry 1983;40:1278.
27. Kimbro JR, Kelly PJ, Cole DJ, Patel PM. Isofluorane and pentobarbital reduce AMPA toxicity in vivo in the rat cerebral cortex. Anesthesiology 2000;92:806-12.
28. Amakawa K, Adachi N, Liu K, Ikemunek K, Fujitani T, Arai T. Effects of pre- and postischemic administration or thiopental on transmitter amino acid release and histologic outcome in gerbils. Anesthesiology 1996;85:1422-30.
29. Schalen W, Messeter K, Nordstrom CH. Complications and side effects during thiopentone therapy patients with severe head injuries. Acta Anaesthesiol Scand 1992;36:369-77.
30. Traeger SM, Henning RJ, Dobkin W, Giannotta S, Weil MH, Weis M. Hemodynamic effects of pentobarbital therapy for intracranial hypertension. Crit Care Med 1983:11:697-701.
31. Barbiturate-induced coma in head injury patients. In: Hutchinson TA, Shanan DR, editors. Drugdex® (System. Micromedex Inc., Greenwood Village (Colorado) (June 2001).
32. Hatano Y, Nakamura K, Moriyama S, Mori K, Toda N. The contractile responses of isolated dog cerebral and extracerebral arteries to oxybarbiturates and thiobarbiturates. Anesthesiology 1989;71:80-6.
33. Cole DJ, Cross LM, Drummond JC, Patel PM, Jacobsen WK. Thiopentone and methohexital, but not pentobarbitone, reduce early focal cerebral ischemic injury in rats. Can J Anaesth 2001;48:807-14.
34. Shibuta S, Kosaka J, Mashimo T, Fukada Y, Yoshiya I. Nitric oxide induced cytotoxicity attenuation by thiopentone sodium but not pentobarbitone sodium in primary brain cultures. Br J Pharmacol 1998;124:804-10.
35. Roesch C, Haselby KA, Paradise RR, Krishna G, Dierdorf S, Wolfe TM, et al. Comparision of cardiovascular effects of thiopental and pentorbarbital al equivalent levels of CNS depression. Anesth Analg 1983;62:749-53.
36. Marmarou A, Anderson RL, Ward JD, Choi SC, Young HF. Impact of ICP instability and hypotension on outcome in patients with severe head trauma. J Neurosurgery 1991;75:S159-S66.
37. The Brain Trauma Foundation. The Americal Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Indications for intracranial pressure monitoring. J Neurotrauma 2000;17:670-80.
38. Murillo F, Muñoz MA, Domínguez JM, Ruano JJ, Gonzalez E, Albert P, et al. Barbitúricos a altas dosis en la hipertensión endocraneal incontrolable. Med Intensiva 1986;10:164-8.
39. Chesnut RM. Medical management of intracranial pressure. In: Head Injury. 4th Ed. New York: Mc Graw-Hill. 2000; p. 229-63.
40. Winer JW, Rosenwasser RH, Jimenez F. Electroencephalographic activity and serum and cerebroespinal fluid pentobarbital levels in determining the therapeutic end point during barbiturate coma. Neurosurgery 1991;29:739-41.
41. Wermeling DP, Blouin RA, Porter WH, Rapp RP. Tibbs PA. Pentobarbital pharmacokinetics in patients with severe head injury. Drug Intell Clin Pharm 1987;21:459-63.
42. Lobato RD, Sarabia R, Cordobés F, Rivas J, Adrados A, Cabrera A, et al. Postraumatic cerebral hemispheric swelling. Analysis of 55 cases studied with computerized tomography. J Neurosurg 1988;68:417-23.
43. Nordstrom CH, Messeter K, Sundbarg G, Schalen W, Werner M, Ryding E. Cerebral blood flow, vasoreactivity, and oxygen consumption during barbiturate therapy in severe traumatic brain lesions. J Neurosurg 1988;68:424-31.